Dementia researchers are leaving no stone unturned in the hunt for new treatments
To tackle these diseases we need to see research into a range of therapeutic approaches, giving us the best chance of finding effective treatments sooner.
Dementia: it’s not all about Alzheimer’s or memory
It’s a common misconception that dementia is all about Alzheimer’s and that it’s all about memory loss.
Solanezumab: Is the first disease-modifying treatment for Alzheimer’s on the horizon?
We’re hearing in the news that a new treatment designed to slow Alzheimer’s has shown benefit in one of the final stages of testing in people. So what’s going on?
Why do some people get dementia and not others?
But why do some people develop the diseases that causes dementia, while others are spared?
Is there a joined-up approach to solve the global issue of dementia?
The world’s largest dementia conference kicked off in Washington D.C. and we’re proud to be representing the work of Alzheimer’s Research UK on this international stage.